site drugs simply not available drugmakers not compelled 2007 federal court decision found fundamental right access experimental drugs terminally ill new law changes pharma companies reasons cautious providing labs drug early stages testing risks benefits wildly uncertain supplies limited production costly company wish save precious stock clinical trials developers concerned drugs poorly fragile dying patients word consequences dire patients scared away studies investors retreat stocks tank work potentially valuable new medicine derailed acts compassion said patients want drug run clinical trial asks kenneth moch president ceo cognition therapeutics pittsburgh happens future patients long career moch hand making drugs available compassionate